Skip Navigation
Oxford Journals
Contact Us
My Basket
My Account
Europace
About This Journal
Contact This Journal
Subscriptions
View Current Issue (Volume 11 Issue 12 )
Archive
Search
Oxford Journals
Medicine
EP Europace
Volume 7, Number s1
Receive this page by email each issue:
[Sign up for eTOCs]
Contents:
Volume 7, Number s1, 2005
[Index by Author]
Other Issues:
Oral Session
Poster Session 1
Poster Session 2
Poster Session 3
Poster Session 4
Author Index
Find articles in this issue containing these words:
[Search ALL Issues]
To see an article
, click its [Full Text] or [PDF] link.
To review many abstracts
, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.
To see one abstract at a time
, click its [Abstract] link.
Oral Session
Clinical aspects and results of catheter ablations: 6 Catheter ablation effect on inflammation in atrial flutter patients
Europace 2005 7: 1; doi:10.1093/europace/7.s1.1
[PDF]
[Request Permissions]
Clinical aspects and results of catheter ablations: 7 Paroxysmal versus persistent atrial flutter: comparison of clinical, echocardiographical and electrophysiological parameters
Europace 2005 7: 1; doi:10.1093/europace/7.s1.1-a
[PDF]
[Request Permissions]
Clinical aspects and results of catheter ablations: 8 Natural history of Wolff-Parkinson-White syndrome. Insights for risk stratification and management
Europace 2005 7: 1; doi:10.1093/europace/7.s1.1-b
[PDF]
[Request Permissions]
Clinical aspects and results of catheter ablations: 9 Long-term outcome of radiofrequency ablation in patients with incessant ventricular tachycardias related to coronary artery disease
Europace 2005 7: 2; doi:10.1093/europace/7.s1.2
[PDF]
[Request Permissions]
Clinical aspects and results of catheter ablations: 10 Long-term prognosis in patients following catheter ablation for bundle branch reentry ventricular tachycardia
Europace 2005 7: 2; doi:10.1093/europace/7.s1.2-a
[PDF]
[Request Permissions]
Clinical aspects and results of catheter ablations: 11 Left ventricular coronary vein mapping in patients with frequent VTs or VT storm
Europace 2005 7: 2; doi:10.1093/europace/7.s1.2-b
[PDF]
[Request Permissions]
Catheter ablation and atrial fibrillation: the days and months after: 35 Evaluation of asymptomatic atrial fibrillation recurrences: CACAF study
Europace 2005 7: 3; doi:10.1093/europace/7.s1.3
[PDF]
[Request Permissions]
Catheter ablation and atrial fibrillation: the days and months after: 36 Paroxysmal atrial fibrillation: long-term results of different ablation strategies according to different arrhythmic patterns
Europace 2005 7: 3; doi:10.1093/europace/7.s1.3-a
[PDF]
[Request Permissions]
Catheter ablation and atrial fibrillation: the days and months after: 37 Recurrence of atrial fibrillation after efficacious radiofrequency transcatheter ablation of regular supraventricular tachycardia
Europace 2005 7: 3-4; doi:10.1093/europace/7.s1.3-b
[PDF]
[Request Permissions]
Catheter ablation and atrial fibrillation: the days and months after: 38 Change of AF variability and change of AF perception after catheter ablation. Implications on follow-up
Europace 2005 7: 4; doi:10.1093/europace/7.s1.4
[PDF]
[Request Permissions]
Catheter ablation and atrial fibrillation: the days and months after: 39 Electrophysiological findings during reablation for recurrence of intermittent atrial fibrillation after pulmonary vein isolation with electroanatomic encircling
Europace 2005 7: 4; doi:10.1093/europace/7.s1.4-a
[PDF]
[Request Permissions]
Catheter ablation and atrial fibrillation: the days and months after: 40 Long-term follow-up of patients after radiofrequency catheter ablation of atrial fibrillation
Europace 2005 7: 4; doi:10.1093/europace/7.s1.4-b
[PDF]
[Request Permissions]
Outcome of pacing in different indications: 24 Permanent direct His bundle pacing does not induce ventricular dyssynchrony as opposed to conventional right ventricular apical DDD pacing
Europace 2005 7: 5; doi:10.1093/europace/7.s1.5
[PDF]
[Request Permissions]
Outcome of pacing in different indications: 25 Determining optimal dual chamber algorithm to favor spontaneous AV conduction: preliminary results of the Saver study
Europace 2005 7: 5; doi:10.1093/europace/7.s1.5-a
[PDF]
[Request Permissions]
Outcome of pacing in different indications: 26 Permanent pacemaker implantation following cardiac surgery: indications and long term follow up
Europace 2005 7: 5-6; doi:10.1093/europace/7.s1.5-b
[PDF]
[Request Permissions]
Outcome of pacing in different indications: 27 Long-term results of VVI and DDD pacing modes in patients with sick sinus syndrome
Europace 2005 7: 6; doi:10.1093/europace/7.s1.6
[PDF]
[Request Permissions]
Outcome of pacing in different indications: 28 Biventricular pacing versus DDD(R) pacing in patients with high-grade AV-block. A randomized comparison
Europace 2005 7: 6; doi:10.1093/europace/7.s1.6-a
[PDF]
[Request Permissions]
Outcome of pacing in different indications: 29 Clinical importance of permanent pacemaker mode selection in patients with complete atrioventricular block
Europace 2005 7: 6; doi:10.1093/europace/7.s1.6-b
[PDF]
[Request Permissions]
Non-invasive risk stratification for ventricular tachycardia: 30 Predictors of mortality in patients with left ventricular dysfunction after coronary bypass surgery: results of 5 years prospective study
Europace 2005 7: 7; doi:10.1093/europace/7.s1.7
[PDF]
[Request Permissions]
Non-invasive risk stratification for ventricular tachycardia: 31 T-wave loop and QRS complex loop variables and mortality in postinfarction patients
Europace 2005 7: 7; doi:10.1093/europace/7.s1.7-a
[PDF]
[Request Permissions]
Non-invasive risk stratification for ventricular tachycardia: 32 Value of microvoltage T-wave alternans to predict ventricular arrhythmia recurrence in ICD patients
Europace 2005 7: 7-8; doi:10.1093/europace/7.s1.7-b
[PDF]
[Request Permissions]
Non-invasive risk stratification for ventricular tachycardia: 33 Mechanisms of the onset and circadian rhythm of ventricular tachyarrhythmias in patients under cardiac resynchronization therapy
Europace 2005 7: 8; doi:10.1093/europace/7.s1.8
[PDF]
[Request Permissions]
Non-invasive risk stratification for ventricular tachycardia: 34 Risk stratification in patients with Brugada syndrome. Analysis of daily variations in 12-lead electrocardiogram (ECG) and signal-averaged electrocardiogram (SAECG)
Europace 2005 7: 8; doi:10.1093/europace/7.s1.8-a
[PDF]
[Request Permissions]
Coronary sinus lead placement: imaging and tools for implantation: 45 Feasibility of cardiac CT for detecting the optimum coronary sinus branch in cardiac resynchronized therapy
Europace 2005 7: 8-9; doi:10.1093/europace/7.s1.8-b
[PDF]
[Request Permissions]
Coronary sinus lead placement: imaging and tools for implantation: 46 Non-invasive visualization of the cardiac venous system using multi-slice computed tomography
Europace 2005 7: 9; doi:10.1093/europace/7.s1.9
[PDF]
[Request Permissions]
Coronary sinus lead placement: imaging and tools for implantation: 47 Coronary venous anatomy and transvenous lead placement at the left ventricular lateral wall
Europace 2005 7: 9; doi:10.1093/europace/7.s1.9-a
[PDF]
[Request Permissions]
Coronary sinus lead placement: imaging and tools for implantation: 48 Left ventricular lead placement within a coronary sinus side branch is feasible using remote magnetic navigation of a guidewire
Europace 2005 7: 9; doi:10.1093/europace/7.s1.9-b
[PDF]
[Request Permissions]
Coronary sinus lead placement: imaging and tools for implantation: 49 Coronarsinus Vein Angioplasty for Implantation of Left Ventricular Leads in Cardiac Resynchronization Therapy
Europace 2005 7: 10; doi:10.1093/europace/7.s1.10
[PDF]
[Request Permissions]
Coronary sinus lead placement: imaging and tools for implantation: 50 Stabilization of the coronary sinus electrode position with stent implantation: a new technique for prevention and treatment of lead dislocation
Europace 2005 7: 10; doi:10.1093/europace/7.s1.10-a
[PDF]
[Request Permissions]
New indications in cardiac resynchronisation therapy: 75 Sleep disorder breathing and heart failure: role of biventricular pacing
Europace 2005 7: 10-11; doi:10.1093/europace/7.s1.10-b
[PDF]
[Request Permissions]
New indications in cardiac resynchronisation therapy: 76 Long-term outcome of heart failure patients treated with cardiac resynchronization therapy: a comparison between diabetic and non-diabetic patients
Europace 2005 7: 11; doi:10.1093/europace/7.s1.11
[PDF]
[Request Permissions]
New indications in cardiac resynchronisation therapy: 77 Cardiac Resynchronization Therapy in very old patients: the InSync/InSync ICD Italian registries
Europace 2005 7: 11; doi:10.1093/europace/7.s1.11-a
[PDF]
[Request Permissions]
New indications in cardiac resynchronisation therapy: 78 Cardiac resynchronization therapy in NYHA II patients: the Insync/Insync ICD Italian registries
Europace 2005 7: 12; doi:10.1093/europace/7.s1.12
[PDF]
[Request Permissions]
New indications in cardiac resynchronisation therapy: 79 Congestive heart failure, atrial fibrillation, chronic RV-pacing and cardiac resynchronization therapy
Europace 2005 7: 12; doi:10.1093/europace/7.s1.12-a
[PDF]
[Request Permissions]
New indications in cardiac resynchronisation therapy: 80 Adult congenital heart disease patients with systemic right ventricle: potential candidates for cardiac resynchronisation therapy
Europace 2005 7: 12-13; doi:10.1093/europace/7.s1.12-b
[PDF]
[Request Permissions]
Clinical implications of QT internal measurements: 63 Corrected QT interval predicts mortality in patients with non-Q-wave anterior wall myocardial infarction
Europace 2005 7: 13; doi:10.1093/europace/7.s1.13
[PDF]
[Request Permissions]
Clinical implications of QT internal measurements: 64 QT interval variability and QT/RR relationship in patients with postinfarction impairment of the left ventricle function and different types of ventricular arrhythmias
Europace 2005 7: 13; doi:10.1093/europace/7.s1.13-a
[PDF]
[Request Permissions]
Clinical implications of QT internal measurements: 65 Repolarization parameters in patients with acute anterior myocardial infarction treated with primary PTCA: relationship with the myocardial perfusion
Europace 2005 7: 13-14; doi:10.1093/europace/7.s1.13-b
[PDF]
[Request Permissions]
Clinical implications of QT internal measurements: 66 Increased dispersion of the repolarization during recovery from exercise
Europace 2005 7: 14; doi:10.1093/europace/7.s1.14
[PDF]
[Request Permissions]
Clinical implications of QT internal measurements: 67 Individual QT/RR relationship: average stability over time does not rule out an individual residual variability implication for the assessment of drug effect on the QT interval
Europace 2005 7: 14; doi:10.1093/europace/7.s1.14-a
[PDF]
[Request Permissions]
Clinical implications of QT internal measurements: 68 Comparison of the effects of a selective If current inhibitor ivabradine and atenolol on the QT interval in patients with coronary artery disease
Europace 2005 7: 14-15; doi:10.1093/europace/7.s1.14-b
[PDF]
[Request Permissions]
Basic aspects of atrial and ventricular arrhythmias: 69 T97C and C193T substitutions in KCNE5: two genetic risk factors for atrial fibrillation
Europace 2005 7: 15; doi:10.1093/europace/7.s1.15
[PDF]
[Request Permissions]
Basic aspects of atrial and ventricular arrhythmias: 70 Neurally induced atrial arrhythmias are eliminated by alpha-adrenergic blockade
Europace 2005 7: 15; doi:10.1093/europace/7.s1.15-a
[PDF]
[Request Permissions]
Basic aspects of atrial and ventricular arrhythmias: 71 Infarct healing and arrhythmias affected by gap junction remodelling in Cx43-deficient mice
Europace 2005 7: 16; doi:10.1093/europace/7.s1.16
[PDF]
[Request Permissions]
Basic aspects of atrial and ventricular arrhythmias: 72 Conduction delay plays a key role in predisposing the heart to ventricular fibrillation in acute regional ischemia
Europace 2005 7: 16; doi:10.1093/europace/7.s1.16-a
[PDF]
[Request Permissions]
Basic aspects of atrial and ventricular arrhythmias: 73 Effect of hypothermia on action potential duration restitution and initiation of ventricular arrhythmias in mouse hearts: an optical mapping study
Europace 2005 7: 16; doi:10.1093/europace/7.s1.16-b
[PDF]
[Request Permissions]
Basic aspects of atrial and ventricular arrhythmias: 74 Development of the right ventricular inflow tract and moderator band as a morphological substrate for mahaim tachycardia
Europace 2005 7: 17; doi:10.1093/europace/7.s1.17
[PDF]
[Request Permissions]
Award session: 93 Results of simultaneous electrophysiologic investigation in 105 prospective HOCM patients during transcoronary ablation of septal hypertrophy (TASH)
Europace 2005 7: 54; doi:10.1093/europace/7.s1.54
[PDF]
[Request Permissions]
Award session: 94 Assessment of atrial overdrive pacing as a treatment for patients with obstructive sleep Apnoea Hypopnoea Syndrome
Europace 2005 7: 54; doi:10.1093/europace/7.s1.54-a
[PDF]
[Request Permissions]
Award session: 95 Early recovery of pulmonary vein potentials does not necessarily predict long-term recurrence of atrial fibrillation
Europace 2005 7: 54-55; doi:10.1093/europace/7.s1.54-b
[PDF]
[Request Permissions]
Award session: 96 The fortuitous individual with a Brugada-like electrocardiogram
Europace 2005 7: 55; doi:10.1093/europace/7.s1.55
[PDF]
[Request Permissions]
Award session: 97 Selective activation of epsilon-PKC in transgenic mice protects against ischemia related reperfusion arrhythmias
Europace 2005 7: 55; doi:10.1093/europace/7.s1.55-a
[PDF]
[Request Permissions]
Resynchronisation therapy: left ventricular implantations and new approaches, new stimulation techniques: 122 Is the unipolar or the bipolar mode more energy efficient in biventricular pacemakers?
Europace 2005 7: 55-56; doi:10.1093/europace/7.s1.55-b
[PDF]
[Request Permissions]
Resynchronisation therapy: left ventricular implantations and new approaches, new stimulation techniques: 123 Cardiac Resynchronization Therapy with an implantable cardiac defibrillator: comparison between transvenous approach and epimyocardial approach for left ventricular lead placement
Europace 2005 7: 56; doi:10.1093/europace/7.s1.56
[PDF]
[Request Permissions]
Resynchronisation therapy: left ventricular implantations and new approaches, new stimulation techniques: 124 Anodal stimulation hinders V-V timing with pacing of the left ventricle first at long V-V intervals but causes triple site ventricular pacing at short V-V intervals
Europace 2005 7: 56; doi:10.1093/europace/7.s1.56-a
[PDF]
[Request Permissions]
Resynchronisation therapy: left ventricular implantations and new approaches, new stimulation techniques: 125 Evaluation of biventricular capture detection using the paced depolarization integral (PDI) method in the chronic canine
Europace 2005 7: 56-57; doi:10.1093/europace/7.s1.56-b
[PDF]
[Request Permissions]
Resynchronisation therapy: left ventricular implantations and new approaches, new stimulation techniques: 126 BiV capture verification utilizing RV coil to can evoked response in CRT-D patients
Europace 2005 7: 57; doi:10.1093/europace/7.s1.57
[PDF]
[Request Permissions]
Resynchronisation therapy: left ventricular implantations and new approaches, new stimulation techniques: 127 Biventricular auto capture is feasible in CHF patients with LBBB
Europace 2005 7: 57; doi:10.1093/europace/7.s1.57-a
[PDF]
[Request Permissions]
Heart failure patients with cardiac pacing: results of upgrading to cardiac resynchronisation therapy: 110 Benefits of cardiac resynchronization therapy extend to patients up-graded from right ventricular to biventricular pacing
Europace 2005 7: 57-58; doi:10.1093/europace/7.s1.57-b
[PDF]
[Request Permissions]
Heart failure patients with cardiac pacing: results of upgrading to cardiac resynchronisation therapy: 111 In patients with dilated cardiomyopathy and ventricular dyssynchrony, upgrading to cardiac resynchronization is beneficial as de novo implant
Europace 2005 7: 58; doi:10.1093/europace/7.s1.58
[PDF]
[Request Permissions]
Heart failure patients with cardiac pacing: results of upgrading to cardiac resynchronisation therapy: 112 Biventricular or right ventricular permanent pacing after atrioventricular nodal ablation in patients with advanced heart failure and chronic atrial fibrillation
Europace 2005 7: 58; doi:10.1093/europace/7.s1.58-a
[PDF]
[Request Permissions]
Heart failure patients with cardiac pacing: results of upgrading to cardiac resynchronisation therapy: 113 Upgrading from right conventional ventricular pacing to biventricular pacing: hemodynamic benefits and technical issues
Europace 2005 7: 58-59; doi:10.1093/europace/7.s1.58-b
[PDF]
[Request Permissions]
Heart failure patients with cardiac pacing: results of upgrading to cardiac resynchronisation therapy: 114 Upgrade to biventricular pacing device of pacemaker holders for antibradycardia indications: the Insync/Insync ICD italian registries
Europace 2005 7: 59; doi:10.1093/europace/7.s1.59
[PDF]
[Request Permissions]
Heart failure patients with cardiac pacing: results of upgrading to cardiac resynchronisation therapy: 115 Patients with right ventricular apical pacing and drug refractory heart failure benefit significantly from cardiac resynchronization therapy
Europace 2005 7: 59; doi:10.1093/europace/7.s1.59-a
[PDF]
[Request Permissions]
Heart rate turbulence: 116 Heart Rate Turbulence is more suitable than Heart Rate Variability to detect transient autonomic changes preceding ventricular arrhythmias
Europace 2005 7: 59-60; doi:10.1093/europace/7.s1.59-b
[PDF]
[Request Permissions]
Heart rate turbulence: 117 "Heart rate turbulence" after short periods of spontaneous, non-sustained ventricular tachycardia and its relation with heart rate variability indexes
Europace 2005 7: 60; doi:10.1093/europace/7.s1.60
[PDF]
[Request Permissions]
Heart rate turbulence: 118 Heart rate turbulence in risk stratification of sudden cardiac death in myocardial infarction survivors - a prospective study
Europace 2005 7: 60; doi:10.1093/europace/7.s1.60-a
[PDF]
[Request Permissions]
Heart rate turbulence: 119 The influence of some clinical data in patients with acute myocardial infarction on heart rate turbulence parameters
Europace 2005 7: 61; doi:10.1093/europace/7.s1.61
[PDF]
[Request Permissions]
Heart rate turbulence: 120 Heart rate turbulence slope triggered by atrial premature complexes correlates with phenylephrine baroreflex sensitivity in the ATRAMI study
Europace 2005 7: 61; doi:10.1093/europace/7.s1.61-a
[PDF]
[Request Permissions]
Heart rate turbulence: 121 Heart Rate Turbulence in patients with myotonic dystrophy type 1: a new marker for arrhythmic risk stratification
Europace 2005 7: 61-62; doi:10.1093/europace/7.s1.61-b
[PDF]
[Request Permissions]
Pulmonary vein ablation and complications: how to avoid?: 279 Regression of phrenic nerve injury after AF ablation
Europace 2005 7: 62; doi:10.1093/europace/7.s1.62
[PDF]
[Request Permissions]
Pulmonary vein ablation and complications: how to avoid?: 280 Pulmonary vein stenosis after ostial cryoisolation in patients with atrial fibrillation?
Europace 2005 7: 62; doi:10.1093/europace/7.s1.62-a
[PDF]
[Request Permissions]
Pulmonary vein ablation and complications: how to avoid?: 281 Incidence of asymptomatic pulmonary vein stenosis in atrial fibrillation ablation. Segmental ostial ablation versus pulmonary veins encircling
Europace 2005 7: 62-63; doi:10.1093/europace/7.s1.62-b
[PDF]
[Request Permissions]
Pulmonary vein ablation and complications: how to avoid?: 282 Recognition of phrenic nerve location for ablation at right pulmonary vein and superior vena cava
Europace 2005 7: 63; doi:10.1093/europace/7.s1.63
[PDF]
[Request Permissions]
Pulmonary vein ablation and complications: how to avoid?: 283 Oesophageal Tagging: a new method to prevent oesophagus perforation during AF ablation
Europace 2005 7: 63; doi:10.1093/europace/7.s1.63-a
[PDF]
[Request Permissions]
Pulmonary vein ablation and complications: how to avoid?: 284 Where is the esophagus? Anatomical implications for ablation of atrial fibrillation
Europace 2005 7: 63-64; doi:10.1093/europace/7.s1.63-b
[PDF]
[Request Permissions]
Long-term follow up of CRT: effects on arrhythmogenesis: 267 Acute and mid-term effect of cardiac resynchronization therapy on mitral regurgitation in patients with severe chronic heart failure
Europace 2005 7: 64; doi:10.1093/europace/7.s1.64
[PDF]
[Request Permissions]
Long-term follow up of CRT: effects on arrhythmogenesis: 268 Biventricular pacing in right bundle-branch block
Europace 2005 7: 64; doi:10.1093/europace/7.s1.64-a
[PDF]
[Request Permissions]
Long-term follow up of CRT: effects on arrhythmogenesis: 269 Cardiac resynchronization therapy does not reduce the incidence of ventricular arrhythmias
Europace 2005 7: 64-65; doi:10.1093/europace/7.s1.64-b
[PDF]
[Request Permissions]
Long-term follow up of CRT: effects on arrhythmogenesis: 270 Left ventricular remodeling after cardiac resynchronization therapy reduces inducibility of ventricular tachy-arrhythmias
Europace 2005 7: 65; doi:10.1093/europace/7.s1.65
[PDF]
[Request Permissions]
Long-term follow up of CRT: effects on arrhythmogenesis: 271 Cardiac re-synchronization may have a beneficial effect on right ventricular mechanical performance
Europace 2005 7: 65; doi:10.1093/europace/7.s1.65-a
[PDF]
[Request Permissions]
Long-term follow up of CRT: effects on arrhythmogenesis: 272 Clinical parameter variation in stable heart failure patients with a resynchronization device
Europace 2005 7: 65; doi:10.1093/europace/7.s1.65-b
[PDF]
[Request Permissions]
ICD therapy in genetic cardiac disease: 273 ICD-therapy in hypertrophic cardiomyopathy: discharge rates of 42 pts in a 2 year follow-up
Europace 2005 7: 66; doi:10.1093/europace/7.s1.66
[PDF]
[Request Permissions]
ICD therapy in genetic cardiac disease: 274 Collective Observatory of BRugadA syndrome (COBRA): a French national multicenter survey
Europace 2005 7: 66; doi:10.1093/europace/7.s1.66-a
[PDF]
[Request Permissions]
ICD therapy in genetic cardiac disease: 275 Long-term prognosis of individuals with right precordial ST-elevation - Brugada syndrome
Europace 2005 7: 66-67; doi:10.1093/europace/7.s1.66-b
[PDF]
[Request Permissions]
ICD therapy in genetic cardiac disease: 276 Clinical follow-up of patients with Short QT syndrome
Europace 2005 7: 67; doi:10.1093/europace/7.s1.67
[PDF]
[Request Permissions]
ICD therapy in genetic cardiac disease: 277 Outcome in patients with arrhythmogenic right ventricular dysplasia and implantable cardioverter-defibrillators
Europace 2005 7: 67; doi:10.1093/europace/7.s1.67-a
[PDF]
[Request Permissions]
ICD therapy in genetic cardiac disease: 278 Sudden cardiac death in the young: is prevention by prospective evaluation feasible?
Europace 2005 7: 67; doi:10.1093/europace/7.s1.67-b
[PDF]
[Request Permissions]
New insights in catheter ablation of ventricular arrhythmia: 331 Catheter ablation of idiopathic multifocal premature ventricular contractions
Europace 2005 7: 101; doi:10.1093/europace/7.s1.101
[PDF]
[Request Permissions]
New insights in catheter ablation of ventricular arrhythmia: 332 Clinical implication of presystolic bipolar potential for successful ablation of ventricular tachycardia originating from the aortic sinus cusp
Europace 2005 7: 101; doi:10.1093/europace/7.s1.101-a
[PDF]
[Request Permissions]
New insights in catheter ablation of ventricular arrhythmia: 333 Substrate modification in ischaemic cardiomyopathy to treat ventricular tachycardia using electroanatomic scar mapping
Europace 2005 7: 101-102; doi:10.1093/europace/7.s1.101-b
[PDF]
[Request Permissions]
New insights in catheter ablation of ventricular arrhythmia: 334 Localization of the critical isthmus of post-infarct reentrant ventricular tachycardia using sinus rhythm electrogram characteristics
Europace 2005 7: 102; doi:10.1093/europace/7.s1.102
[PDF]
[Request Permissions]
New insights in catheter ablation of ventricular arrhythmia: 335 Ablation of unmappable post-MI ventricular tachycardia using voltage-map in sinus rhythm
Europace 2005 7: 102; doi:10.1093/europace/7.s1.102-a
[PDF]
[Request Permissions]
New insights in catheter ablation of ventricular arrhythmia: 336 Subendocardial conduction in normal and infarcted human hearts: re-evaluation of an old concept to guide ventricular tachycardia ablation during sinus rhythm
Europace 2005 7: 102-103; doi:10.1093/europace/7.s1.102-b
[PDF]
[Request Permissions]
Atrial tissue ablation: from flutter to atrial tachycardia: 319 Temporal pattern of conduction recurrence during radiofrequency ablation for typical atrial flutter
Europace 2005 7: 103; doi:10.1093/europace/7.s1.103
[PDF]
[Request Permissions]
Atrial tissue ablation: from flutter to atrial tachycardia: 320 Early isthmus conduction recovery in atrial flutter ablation
Europace 2005 7: 103; doi:10.1093/europace/7.s1.103-a
[PDF]
[Request Permissions]
Atrial tissue ablation: from flutter to atrial tachycardia: 321 The incidence of fractionated electrograms decreases with increasing distance from the origin of focal atrial tachycardias
Europace 2005 7: 103-104; doi:10.1093/europace/7.s1.103-b
[PDF]
[Request Permissions]
Atrial tissue ablation: from flutter to atrial tachycardia: 322 Characteristic of focal atrial tachycardia arising from crista terminalis or coronary sinus with multiple activation sequences
Europace 2005 7: 104; doi:10.1093/europace/7.s1.104
[PDF]
[Request Permissions]
Atrial tissue ablation: from flutter to atrial tachycardia: 323 Mechanisms of right atrial tachycardia occurring late after surgical closure of atrial septal defects
Europace 2005 7: 104; doi:10.1093/europace/7.s1.104-a
[PDF]
[Request Permissions]
Atrial tissue ablation: from flutter to atrial tachycardia: 324 Incidence and long-term outcome of atrial flutter occurring in the post-operative course of non congenital cardiac surgery: is radiofrequency ablation immediately indicated?
Europace 2005 7: 104; doi:10.1093/europace/7.s1.104-b
[PDF]
[Request Permissions]
Optimisation of ICD therapy DFT how to reduce it?: 325 The quick implantable cardioverter defibrillator trial (Quick-ICD) is an EPS and a DFT-testing still mandatory in patients with an indication for ICD-implantation?
Europace 2005 7: 105; doi:10.1093/europace/7.s1.105
[PDF]
[Request Permissions]
Optimisation of ICD therapy DFT how to reduce it?: 326 Antitachycardia burst pacing in spontaneous ventricular tachycardias: how many pacing sequences should be programmed?
Europace 2005 7: 105; doi:10.1093/europace/7.s1.105-a
[PDF]
[Request Permissions]
Optimisation of ICD therapy DFT how to reduce it?: 327 ICD patients with elevated defibrillation threshold: clinical behavior and therapeutic alternatives
Europace 2005 7: 105; doi:10.1093/europace/7.s1.105-b
[PDF]
[Request Permissions]
Optimisation of ICD therapy DFT how to reduce it?: 328 Reduced defibrillation energy by vagal stimulation
Europace 2005 7: 105-106; doi:10.1093/europace/7.s1.105-c
[PDF]
[Request Permissions]
Optimisation of ICD therapy DFT how to reduce it?: 329 Regional programming differences in the worldwide empiric trial
Europace 2005 7: 106; doi:10.1093/europace/7.s1.106
[PDF]
[Request Permissions]
Optimisation of ICD therapy DFT how to reduce it?: 330 Standardized extensive ATP programming reduces shocks for VT/VF compared to usual physician programming: results from the EMPIRIC trial
Europace 2005 7: 106-107; doi:10.1093/europace/7.s1.106-a
[PDF]
[Request Permissions]
Mechanisms of atrial fibrillation: 476 Chronic left atrial volume and pressure overload in the goat: a new model of sustained atrial fibrillation
Europace 2005 7: 107; doi:10.1093/europace/7.s1.107
[PDF]
[Request Permissions]
Mechanisms of atrial fibrillation: 477 Effect of chronic amiodarone therapy on the excitable gap during typical human atrial flutter
Europace 2005 7: 107; doi:10.1093/europace/7.s1.107-a
[PDF]
[Request Permissions]
Mechanisms of atrial fibrillation: 478 The role of matrix metalloproteinases in the development of atrial fibrillation
Europace 2005 7: 107-108; doi:10.1093/europace/7.s1.107-b
[PDF]
[Request Permissions]
Mechanisms of atrial fibrillation: 479 Role of Bachmann's bundle during chronic atrial fibrillation in patients with mitral valve disease
Europace 2005 7: 108; doi:10.1093/europace/7.s1.108
[PDF]
[Request Permissions]
Mechanisms of atrial fibrillation: 480 RR intervals have an individually specific pattern in atrial fibrillation
Europace 2005 7: 108; doi:10.1093/europace/7.s1.108-a
[PDF]
[Request Permissions]
Mechanisms of atrial fibrillation: 481 Posterior wall of left atrium and pulmonary veins refractory period is related to atrial fibrillation inducibility in pigs
Europace 2005 7: 108; doi:10.1093/europace/7.s1.108-b
[PDF]
[Request Permissions]
Electrical and mechanical predictors in response to cardiac resynchronisation therapy: 464 Tissue Doppler imaging predicts improvement in left ventricular performance and cardiac synchrony after biventricular pacing in advanced heart failure
Europace 2005 7: 109; doi:10.1093/europace/7.s1.109
[PDF]
[Request Permissions]
Electrical and mechanical predictors in response to cardiac resynchronisation therapy: 465 Biventricular pacing in heart failure. An echocardiographic method to identify the long term "responders"
Europace 2005 7: 109; doi:10.1093/europace/7.s1.109-a
[PDF]
[Request Permissions]
Electrical and mechanical predictors in response to cardiac resynchronisation therapy: 466 Reverse left ventricular remodeling after cardiac resynchronization therapy is predicted by electrocardiographic and electrophysiological parameters
Europace 2005 7: 109-110; doi:10.1093/europace/7.s1.109-b
[PDF]
[Request Permissions]
Electrical and mechanical predictors in response to cardiac resynchronisation therapy: 467 Cardiac resynchronization in long term follow up: analysis of clinical response predictors
Europace 2005 7: 110; doi:10.1093/europace/7.s1.110
[PDF]
[Request Permissions]
Electrical and mechanical predictors in response to cardiac resynchronisation therapy: 468 Impact of left and biventricular pacing on aortic flow, mitral regurgitation and ventricular dyssynchrony during exercise: an exercise-echocardiographic study
Europace 2005 7: 110; doi:10.1093/europace/7.s1.110-a
[PDF]
[Request Permissions]
Electrical and mechanical predictors in response to cardiac resynchronisation therapy: 469 Uncomplicated left bundle branch block in patients with dilated cardiomyopathy is associated with higher long-term benefit of cardiac resynchronization therapy
Europace 2005 7: 110; doi:10.1093/europace/7.s1.110-b
[PDF]
[Request Permissions]
How to minimise inappropriate therapy in ICD therapy: new approaches: 470 Transvenous ICD lead failure during long term-follow-up: incidence, timing and implications
Europace 2005 7: 111; doi:10.1093/europace/7.s1.111
[PDF]
[Request Permissions]
How to minimise inappropriate therapy in ICD therapy: new approaches: 471 Stability of the second generation of ICD morphology discrimination in different patient positions
Europace 2005 7: 111; doi:10.1093/europace/7.s1.111-a
[PDF]
[Request Permissions]
How to minimise inappropriate therapy in ICD therapy: new approaches: 472 Incidence of inappropriate therapies in dual-chamber ICDs
Europace 2005 7: 111; doi:10.1093/europace/7.s1.111-b
[PDF]
[Request Permissions]
How to minimise inappropriate therapy in ICD therapy: new approaches: 473 Abnormal electric phenomena after ICD implantation. Prevalence and diagnostic role in the ICD clinic
Europace 2005 7: 112; doi:10.1093/europace/7.s1.112
[PDF]
[Request Permissions]
How to minimise inappropriate therapy in ICD therapy: new approaches: 474 Low resting heart rate protects from ventricular arrhythmias in patients with implantable cardioverter defibrillators
Europace 2005 7: 112; doi:10.1093/europace/7.s1.112-a
[PDF]
[Request Permissions]
How to minimise inappropriate therapy in ICD therapy: new approaches: 475 T wave oversensing by an implantable cardioverter defibrillator after successful ablation of malignant Purkinje ectopy
Europace 2005 7: 112; doi:10.1093/europace/7.s1.112-b
[PDF]
[Request Permissions]
Clinical and epidemiological aspects Atrial fibrillation: 489 Diabetes mellitus increases the risk for atrial fibrillation and flatter
Europace 2005 7: 150; doi:10.1093/europace/7.s1.150
[PDF]
[Request Permissions]
Clinical and epidemiological aspects Atrial fibrillation: 490 Lone atrial fibrillation and Inflammation: could an inflammation marker predict the recurrences?
Europace 2005 7: 150; doi:10.1093/europace/7.s1.150-a
[PDF]
[Request Permissions]
Clinical and epidemiological aspects Atrial fibrillation: 491 Association between serum thyroid hormone concentrations and occurrence of atrial fibrillation in a large community-based population of elderly subjects (The Birmingham Elderly Thyroid Study)
Europace 2005 7: 150-151; doi:10.1093/europace/7.s1.150-b
[PDF]
[Request Permissions]
Clinical and epidemiological aspects Atrial fibrillation: 492 Structural heart disease increases duration and burden but not frequency of atrial fibrillation recurrence in patients with pacemakers
Europace 2005 7: 151; doi:10.1093/europace/7.s1.151
[PDF]
[Request Permissions]
Clinical and epidemiological aspects Atrial fibrillation: 493 Viral infection in patients with lone atrial fibrillation
Europace 2005 7: 151; doi:10.1093/europace/7.s1.151-a
[PDF]
[Request Permissions]
Clinical and epidemiological aspects Atrial fibrillation: 494 Atrial fibrillation in patients with ischemic heart disease and obesity
Europace 2005 7: 151; doi:10.1093/europace/7.s1.151-b
[PDF]
[Request Permissions]
Sleep and arrhythmias: 519 Sleep parameters in patients using pacemakers (PM) with sleep rate function on
Europace 2005 7: 152; doi:10.1093/europace/7.s1.152
[PDF]
[Request Permissions]
Sleep and arrhythmias: 520 CPAP therapy reduces atrial fibrillation burden in Pacemaker patients with Cheyne-Stokes breathing
Europace 2005 7: 152; doi:10.1093/europace/7.s1.152-a
[PDF]
[Request Permissions]
Sleep and arrhythmias: 521 Atrial antitachycardia pacing is most effective at night
Europace 2005 7: 152; doi:10.1093/europace/7.s1.152-b
[PDF]
[Request Permissions]
Sleep and arrhythmias: 522 Atrial overdrive pacing and sleep apnea in a pacemaker population
Europace 2005 7: 153; doi:10.1093/europace/7.s1.153
[PDF]
[Request Permissions]
Sleep and arrhythmias: 523 Evaluation of Epworth sleepiness scale in a population of dual-chamber-pacemaker patients
Europace 2005 7: 153; doi:10.1093/europace/7.s1.153-a
[PDF]
[Request Permissions]
Sleep and arrhythmias: 524 Inter-night variability of sleep disordered breathing
Europace 2005 7: 153-154; doi:10.1093/europace/7.s1.153-b
[PDF]
[Request Permissions]
Haemodynamic and humoral indices for dyssynchrony: 507 Acute hemodynamic studies with multi-site pacing can identify candidates for right ventricular bifocal pacing in advanced heart failure
Europace 2005 7: 154; doi:10.1093/europace/7.s1.154
[PDF]
[Request Permissions]
Haemodynamic and humoral indices for dyssynchrony: 508 Differential responses of brain natriuretic peptide to asynchronous ventricular pacing in patients with normal and impaired left ventricular ejection function
Europace 2005 7: 154; doi:10.1093/europace/7.s1.154-a
[PDF]
[Request Permissions]
Haemodynamic and humoral indices for dyssynchrony: 509 His-septal region as an alternative pacing site: early results
Europace 2005 7: 154-155; doi:10.1093/europace/7.s1.154-b
[PDF]
[Request Permissions]
Haemodynamic and humoral indices for dyssynchrony: 510 Similar degree of mechanical left ventricular dyssynchrony between RV outflow tract and apex pacing for permanent pacemaker site: studied by strain Doppler image
Europace 2005 7: 155; doi:10.1093/europace/7.s1.155
[PDF]
[Request Permissions]
Haemodynamic and humoral indices for dyssynchrony: 511 AV interval optimalization by using finger pulse oximetry signal amplitude changes in sequentially paced patients
Europace 2005 7: 155; doi:10.1093/europace/7.s1.155-a
[PDF]
[Request Permissions]
Haemodynamic and humoral indices for dyssynchrony: 512 Brain Natriuretic Peptides in the assessment of left ventricular remodelling following right ventricular pacing
Europace 2005 7: 155-156; doi:10.1093/europace/7.s1.155-b
[PDF]
[Request Permissions]
Automatic threshold evolution New algorithms: 513 Evaluation of ventricular capture detection using the far-field evoked response recorded from the atrium
Europace 2005 7: 156; doi:10.1093/europace/7.s1.156
[PDF]
[Request Permissions]
Automatic threshold evolution New algorithms: 514 Effects of ventricular automatic capture on device longevity in dual chamber rate responsive pacemakers
Europace 2005 7: 156; doi:10.1093/europace/7.s1.156-a
[PDF]
[Request Permissions]
Automatic threshold evolution New algorithms: 515 Clinical performance of a new atrial automatic threshold testing algorithm
Europace 2005 7: 156-157; doi:10.1093/europace/7.s1.156-b
[PDF]
[Request Permissions]
Automatic threshold evolution New algorithms: 516 Improved performance of new AutoCapture algorithm with non low polarization ventricular pacing leads
Europace 2005 7: 157; doi:10.1093/europace/7.s1.157
[PDF]
[Request Permissions]
Automatic threshold evolution New algorithms: 517 The auto capture
TM
function can be used for high septal right ventricular pacing
Europace 2005 7: 157; doi:10.1093/europace/7.s1.157-a
[PDF]
[Request Permissions]
Automatic threshold evolution New algorithms: 518 Evaluation of a rate overdrive algorithm for reliable automatic atrial capture threshold measurement
Europace 2005 7: 157-158; doi:10.1093/europace/7.s1.157-b
[PDF]
[Request Permissions]
Long-term performance of left ventricular leads: 651 Evolution of left and right ventricular capture thresholds over time in patients receiving cardiac re-synchronization therapy
Europace 2005 7: 158; doi:10.1093/europace/7.s1.158
[PDF]
[Request Permissions]
Long-term performance of left ventricular leads: 652 CRT systems with programmable multiple pacing configurations and a bipolar LV lead may help to maintain capture, conserve battery life and avoid phrenic nerve stimulation
Europace 2005 7: 158; doi:10.1093/europace/7.s1.158-a
[PDF]
[Request Permissions]
Long-term performance of left ventricular leads: 653 Does high LV-electrodes threshold predict suboptimal outcome in CRT?
Europace 2005 7: 158-159; doi:10.1093/europace/7.s1.158-b
[PDF]
[Request Permissions]
Long-term performance of left ventricular leads: 654 Biventricular pacing: 18 months follow-up of ventricular leads electrical variables
Europace 2005 7: 159; doi:10.1093/europace/7.s1.159
[PDF]
[Request Permissions]
Long-term performance of left ventricular leads: 655 The effect of cardiac resynchronization therapy on patients with right heart failure
Europace 2005 7: 159; doi:10.1093/europace/7.s1.159-a
[PDF]
[Request Permissions]
Long-term performance of left ventricular leads: 656 Are all left ventricular pacing leads created equal?
Europace 2005 7: 159-160; doi:10.1093/europace/7.s1.159-b
[PDF]
[Request Permissions]
Mapping and ablation of AV nodal reentrant tachycardia: 681 Characteristics of antegrade slow pathway conduction before and after catheter ablation of retrograde slow pathway in patients with fast-slow uncommon atrioventricular nodal reentrant tachycardia
Europace 2005 7: 160; doi:10.1093/europace/7.s1.160
[PDF]
[Request Permissions]
Mapping and ablation of AV nodal reentrant tachycardia: 682 Delineation of atrioventricular nodal reentrant tachycardia circuit on the right atrium using electro-anatomical mapping system
Europace 2005 7: 160; doi:10.1093/europace/7.s1.160-a
[PDF]
[Request Permissions]
Mapping and ablation of AV nodal reentrant tachycardia: 683 Comparison of conventional versus Localiza-guided slow pathway ablation for the treatment of atrio-ventricular nodal reentrant tachycardia
Europace 2005 7: 160-161; doi:10.1093/europace/7.s1.160-b
[PDF]
[Request Permissions]
Mapping and ablation of AV nodal reentrant tachycardia: 684 Differences in the optimal ablation site in AVNRT ablation between cryothermal and radiofrequency energy. Results of the CRAVT Trial
Europace 2005 7: 161; doi:10.1093/europace/7.s1.161
[PDF]
[Request Permissions]
Mapping and ablation of AV nodal reentrant tachycardia: 685 Ice mapping during tachycardia in close proximity to the AV node is safe and offers advantages for transcatheter ablation procedures
Europace 2005 7: 161; doi:10.1093/europace/7.s1.161-a
[PDF]
[Request Permissions]
Mapping and ablation of AV nodal reentrant tachycardia: 686 Magnetic navigation in atrioventricular nodal reentrant tachycardia (MAVT) study: a learning curve for ablation with magnet catheters
Europace 2005 7: 161-162; doi:10.1093/europace/7.s1.161-b
[PDF]
[Request Permissions]
Pulmonary vein ablation: technical issues: 669 A novel radiofrequency current application technique for pulmonary vein isolation in patients with atrial fibrillation
Europace 2005 7: 162; doi:10.1093/europace/7.s1.162
[PDF]
[Request Permissions]
Pulmonary vein ablation: technical issues: 670 Recurrence of PV conduction and atrial fibrillation after pulmonary vein isolation: segmental versus circumferential strategy
Europace 2005 7: 162; doi:10.1093/europace/7.s1.162-a
[PDF]
[Request Permissions]
Pulmonary vein ablation: technical issues: 671 Perpetuation of induced atrial fibrillation can predict the recurrence after extensive encircling isolation of ipsilateral pulmonary vein
Europace 2005 7: 162-163; doi:10.1093/europace/7.s1.162-b
[PDF]
[Request Permissions]
Pulmonary vein ablation: technical issues: 672 Impact of pulmonary veins atypical anatomy on atrial fibrillation ablation outcomes in segmental ostial approach
Europace 2005 7: 163; doi:10.1093/europace/7.s1.163
[PDF]
[Request Permissions]
Pulmonary vein ablation: technical issues: 673 TEE evaluation of pulmonary vein flow and left ventricular function after circumferential RF catheter ablation of pulmonary veins due to AF. A prospective follow-up study
Europace 2005 7: 163; doi:10.1093/europace/7.s1.163-a
[PDF]
[Request Permissions]
Pulmonary vein ablation: technical issues: 674 Catheter ablation for persistent and permanent atrial fibrillation: left atrial approach versus biatrial approach
Europace 2005 7: 163-164; doi:10.1093/europace/7.s1.163-b
[PDF]
[Request Permissions]
Where to pace and where not to pace?: 675 LV functionality changes after RV apical pacing: the "WHERE" study
Europace 2005 7: 164; doi:10.1093/europace/7.s1.164
[PDF]
[Request Permissions]
Where to pace and where not to pace?: 676 Right ventricular pacing does not affect the occurrence of atrial tachyarrhythmias in dual chamber pacemaker patients
Europace 2005 7: 164; doi:10.1093/europace/7.s1.164-a
[PDF]
[Request Permissions]
Where to pace and where not to pace?: 677 Is right ventricular outflow tract pacing superior to right ventricular apex stimulation? Long-term observation
Europace 2005 7: 164-165; doi:10.1093/europace/7.s1.164-b
[PDF]
[Request Permissions]
Where to pace and where not to pace?: 678 The incidence of ventricular pacing in patients with sinus node dysfunction and preserved AV conduction can be reduced using long AV delays and the DDIR mode
Europace 2005 7: 165; doi:10.1093/europace/7.s1.165
[PDF]
[Request Permissions]
Where to pace and where not to pace?: 679 Acute haemodynamic effects of permanent, direct His bundle pacing
Europace 2005 7: 165; doi:10.1093/europace/7.s1.165-a
[PDF]
[Request Permissions]
Where to pace and where not to pace?: 680 Factors influencing differences of RVA & RVOT pacing hemodynamic effects
Europace 2005 7: 165-166; doi:10.1093/europace/7.s1.165-b
[PDF]
[Request Permissions]
Preventive pacing in atrial fibrillation 1: 707 Long-term reduction of atrial fibrillation recurrences in patients paced for bradycardia-tachycardia syndrome
Europace 2005 7: 201; doi:10.1093/europace/7.s1.201
[PDF]
[Request Permissions]
Preventive pacing in atrial fibrillation 1: 708 Post mode-switch overdrive pacing (pmop) reduces the occurrence of atrial fibrillation episodes during the overdrive period
Europace 2005 7: 201; doi:10.1093/europace/7.s1.201-a
[PDF]
[Request Permissions]
Preventive pacing in atrial fibrillation 1: 709 Prospective evaluation of atrial electrophysiology to predict the efficacy of pacing site for AF prevention: a pilot study
Europace 2005 7: 201-202; doi:10.1093/europace/7.s1.201-b
[PDF]
[Request Permissions]
Preventive pacing in atrial fibrillation 1: 710 AF prevention by atrial overdrive and AVD optimization
Europace 2005 7: 202; doi:10.1093/europace/7.s1.202
[PDF]
[Request Permissions]
Preventive pacing in atrial fibrillation 1: 711 Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device
Europace 2005 7: 202; doi:10.1093/europace/7.s1.202-a
[PDF]
[Request Permissions]
Preventive pacing in atrial fibrillation 1: 712 Individualised selection of pacing algorithms for the prevention of recurrent atrial fibrillation: results from the VIP registry
Europace 2005 7: 202-203; doi:10.1093/europace/7.s1.202-b
[PDF]
[Request Permissions]
Clinical and electrocardiographical aspects of Brugada syndrome: 737 Differences of heart rate variability between symptomatic and asymptomatic patients with Brugada syndrome
Europace 2005 7: 203; doi:10.1093/europace/7.s1.203
[PDF]
[Request Permissions]
Clinical and electrocardiographical aspects of Brugada syndrome: 738 Spontaneous augmentation of ST elevation is related to clinical predictors of outcome in Brugada syndrome
Europace 2005 7: 203; doi:10.1093/europace/7.s1.203-a
[PDF]
[Request Permissions]
Clinical and electrocardiographical aspects of Brugada syndrome: 739 Positive ajmaline challenge in arrhythmogenic right ventricular dysplasia: Brugada syndrome or both?
Europace 2005 7: 203-204; doi:10.1093/europace/7.s1.203-b
[PDF]
[Request Permissions]
Clinical and electrocardiographical aspects of Brugada syndrome: 740 Electrocardiographic predictors of Brugada type response during Na channel blockade challenge
Europace 2005 7: 204; doi:10.1093/europace/7.s1.204
[PDF]
[Request Permissions]
Clinical and electrocardiographical aspects of Brugada syndrome: 741 Clinical characteristics and short-term outcome of patients diagnosed with Brugada syndrome and a basal non-diagnostic ECG
Europace 2005 7: 204; doi:10.1093/europace/7.s1.204-a
[PDF]
[Request Permissions]
Clinical and electrocardiographical aspects of Brugada syndrome: 742 Analysis of distance after J point to assess transient augmentation of st-segment elevation in Brugada syndrome
Europace 2005 7: 204-205; doi:10.1093/europace/7.s1.204-b
[PDF]
[Request Permissions]
Non-invasive evaluation in patients with myocardial infarction: 725 Dynamics of the nondipolar components of the T-wave during initial course of thrombolyzed ST-elevation myocardial infarction
Europace 2005 7: 205; doi:10.1093/europace/7.s1.205
[PDF]
[Request Permissions]
Non-invasive evaluation in patients with myocardial infarction: 726 HRV assessment depending on cardiac arrest in acute myocardial infarction
Europace 2005 7: 205; doi:10.1093/europace/7.s1.205-a
[PDF]
[Request Permissions]
Non-invasive evaluation in patients with myocardial infarction: 727 A novel heart rate variability index of cardiac vagal outflow predicts sudden cardiac death after an acute myocardial infarction
Europace 2005 7: 205-206; doi:10.1093/europace/7.s1.205-b
[PDF]
[Request Permissions]
Non-invasive evaluation in patients with myocardial infarction: 728 Short QT interval measured in late phase after myocardial infarction is new and promising risk predictor
Europace 2005 7: 206; doi:10.1093/europace/7.s1.206
[PDF]
[Request Permissions]
Non-invasive evaluation in patients with myocardial infarction: 729 Ultra short-term assessment of heart rate variability for risk stratification after acute myocardial infarction
Europace 2005 7: 206; doi:10.1093/europace/7.s1.206-a
[PDF]
[Request Permissions]
Non-invasive evaluation in patients with myocardial infarction: 730 T-wave alternans determinants in patients after acute anterior myocardial infarction
Europace 2005 7: 206-207; doi:10.1093/europace/7.s1.206-b
[PDF]
[Request Permissions]
New advances in diagnosis and management of syncope: 731 Applicability of European guidelines for the management of syncope at the emergency department
Europace 2005 7: 207; doi:10.1093/europace/7.s1.207
[PDF]
[Request Permissions]
New advances in diagnosis and management of syncope: 732 Is the outcome of nitroglycerine stimulated head-up tilt test influenced by the duration of passive phase?
Europace 2005 7: 207; doi:10.1093/europace/7.s1.207-a
[PDF]
[Request Permissions]
New advances in diagnosis and management of syncope: 733 Vasovagal syncope: prognostic factors for syncope recurrences
Europace 2005 7: 207-208; doi:10.1093/europace/7.s1.207-b
[PDF]
[Request Permissions]
New advances in diagnosis and management of syncope: 734 Diagnostic yield of implantable loop recorder after a standardized work-up in patients with unexplained syncope
Europace 2005 7: 208; doi:10.1093/europace/7.s1.208
[PDF]
[Request Permissions]
New advances in diagnosis and management of syncope: 735 Proposed electrocardiographic classification of spontaneous syncope documented by an Implantable Loop Recorder
Europace 2005 7: 208; doi:10.1093/europace/7.s1.208-a
[PDF]
[Request Permissions]
New advances in diagnosis and management of syncope: 736 Impact of an educational process on the management of patients admitted for syncope
Europace 2005 7: 208-209; doi:10.1093/europace/7.s1.208-b
[PDF]
[Request Permissions]
Preventive pacing in atrial fibrillation 2: 857 Efficacy of right atrial pacing preference in the prevention of paroxysmal atrial fibrillation: atrial pacing preference study (APP study)
Europace 2005 7: 209; doi:10.1093/europace/7.s1.209
[PDF]
[Request Permissions]
Preventive pacing in atrial fibrillation 2: 858 Does AF suppression pacing promote reverse electrical remodelling of the atria?
Europace 2005 7: 209; doi:10.1093/europace/7.s1.209-a
[PDF]
[Request Permissions]
Preventive pacing in atrial fibrillation 2: 859 Outcome of preventive atrial stimulation algorithms in patients with coronary heart disease
Europace 2005 7: 209-210; doi:10.1093/europace/7.s1.209-b
[PDF]
[Request Permissions]
Preventive pacing in atrial fibrillation 2: 860 Atrial pacing algorithms vs. high atrial pacing rate in the prevention of atrial fibrillation paroxysms
Europace 2005 7: 210; doi:10.1093/europace/7.s1.210
[PDF]
[Request Permissions]
Preventive pacing in atrial fibrillation 2: 861 Overdrive pacing reduces the frequency of premature atrial contractions
Europace 2005 7: 210; doi:10.1093/europace/7.s1.210-a
[PDF]
[Request Permissions]
Preventive pacing in atrial fibrillation 2: 862 What is the minimum pacing rate to stabilize ventricular rhythm in patients with atrial fibrillation?
Europace 2005 7: 210; doi:10.1093/europace/7.s1.210-b
[PDF]
[Request Permissions]
New pharmacological therapies for atrial fibrillation: 887 Angiotensin receptor blockers and/or angiotensin-converting enzyme inhibitors in the prevention of atrial fibrillation. Meta-analysis of randomized controlled clinical trials
Europace 2005 7: 211; doi:10.1093/europace/7.s1.211
[PDF]
[Request Permissions]
New pharmacological therapies for atrial fibrillation: 888 Prevention of postoperative atrial fibrillation after coronary artery bypass surgery by N-3 fatty acids
Europace 2005 7: 211; doi:10.1093/europace/7.s1.211-a
[PDF]
[Request Permissions]
New pharmacological therapies for atrial fibrillation: 889 Treatment with an Angiotensin Receptor Blocker to Maintain Sinus Rhythm in Lone Atrial Fibrillation Patients. A Prospective and Randomized Study
Europace 2005 7: 211; doi:10.1093/europace/7.s1.211-b
[PDF]
[Request Permissions]
New pharmacological therapies for atrial fibrillation: 890 Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation. The NASPEAF trial
Europace 2005 7: 211-212; doi:10.1093/europace/7.s1.211-c
[PDF]
[Request Permissions]
New pharmacological therapies for atrial fibrillation: 891 Left atrial size and recent onset of the atrial fibrillation/flutter predict the efficacy of a pure k channel blocker, nifekalant
Europace 2005 7: 212; doi:10.1093/europace/7.s1.212
[PDF]
[Request Permissions]
New pharmacological therapies for atrial fibrillation: 892 Statin therapy is associated with a decreased rate of atrial fibrillation in patients with a permanent pacemaker
Europace 2005 7: 212; doi:10.1093/europace/7.s1.212-a
[PDF]
[Request Permissions]
Optimisation of haemodynamic response to resynchronisation therapy: which method, which parameter?: 875 Optimization of the AV-delay in cardiac resynchronization therapy using an implanted hemodynamic monitor
Europace 2005 7: 212-213; doi:10.1093/europace/7.s1.212-b
[PDF]
[Request Permissions]
Optimisation of haemodynamic response to resynchronisation therapy: which method, which parameter?: 876 Electrocardiographic optimization of interventricular delay in cardiac resynchronization therapy: correlation with echocardiography
Europace 2005 7: 213; doi:10.1093/europace/7.s1.213
[PDF]
[Request Permissions]
Optimisation of haemodynamic response to resynchronisation therapy: which method, which parameter?: 877 A new automated algorithm for optimizing AV delay to improve global LV contractile function with cardiac resynchonization therapy
Europace 2005 7: 213; doi:10.1093/europace/7.s1.213-a
[PDF]
[Request Permissions]
Optimisation of haemodynamic response to resynchronisation therapy: which method, which parameter?: 878 Exercise-echocardiographic optimization of the interventricular delay programming in patients with sequential biventricular pacing
Europace 2005 7: 214; doi:10.1093/europace/7.s1.214
[PDF]
[Request Permissions]
Optimisation of haemodynamic response to resynchronisation therapy: which method, which parameter?: 879 Velocity index and optimal AV and VV delay in atrial sensed biventricular pacing
Europace 2005 7: 214; doi:10.1093/europace/7.s1.214-a
[PDF]
[Request Permissions]
Optimisation of haemodynamic response to resynchronisation therapy: which method, which parameter?: 880 What is the best optimization strategy using AV and VV delay in cardiac resynchronization therapy?
Europace 2005 7: 214-215; doi:10.1093/europace/7.s1.214-b
[PDF]
[Request Permissions]
Further insight in diagnosis of syncope: 881 The Plymouth falls intervention study: a randomised, controlled trial of a multifactorial intervention in the prevention of falls in the elderly: preliminary cardiological results
Europace 2005 7: 215; doi:10.1093/europace/7.s1.215
[PDF]
[Request Permissions]
Further insight in diagnosis of syncope: 882 Adenosine triphosphate test: is it dangerous?
Europace 2005 7: 215; doi:10.1093/europace/7.s1.215-a
[PDF]
[Request Permissions]
Further insight in diagnosis of syncope: 883 The lack of significant activation of RAA system during tilt-induced VVS is a risk factor for syncope recurrence during follow-up
Europace 2005 7: 215-216; doi:10.1093/europace/7.s1.215-b
[PDF]
[Request Permissions]
Further insight in diagnosis of syncope: 884 Predictive models of neurovegetative and rhythmic causes of syncope: fact or fantasy?
Europace 2005 7: 216; doi:10.1093/europace/7.s1.216
[PDF]
[Request Permissions]
Further insight in diagnosis of syncope: 885 The bradycardia-hypotension reaction during head-up tilt test: clinical and hemodynamic characteristics related to blood pressure and heart rate behavior during the early stage of the test
Europace 2005 7: 216; doi:10.1093/europace/7.s1.216-a
[PDF]
[Request Permissions]
Further insight in diagnosis of syncope: 886 Cardiovascular effects and risk of syncope related to donepezil in Alzheimer's disease
Europace 2005 7: 216-217; doi:10.1093/europace/7.s1.216-b
[PDF]
[Request Permissions]
Atrial fibrillation and the cardiac surgeon: 898 Experimental study of thoracoscopic obliteration of the left atrial appendage in prevention of thromboembolism in atrial fibrillation
Europace 2005 7: 218; doi:10.1093/europace/7.s1.218
[PDF]
[Request Permissions]
Atrial fibrillation and the cardiac surgeon: 899 One year follow up data predict late outcome of unmodified maze III surgery for atrial fibrillation with and without concomitant heart surgery
Europace 2005 7: 218; doi:10.1093/europace/7.s1.218-a
[PDF]
[Request Permissions]
Atrial fibrillation and the cardiac surgeon: 900 What kind of rhythm have patients after radiofrequency maze procedure?
Europace 2005 7: 218; doi:10.1093/europace/7.s1.218-b
[PDF]
[Request Permissions]
Atrial fibrillation and the cardiac surgeon: 901 Surgical treatment of atrial fibrillation with new liquid nitrogen cryothermy - clinical experience, mid- and long-term results
Europace 2005 7: 219; doi:10.1093/europace/7.s1.219
[PDF]
[Request Permissions]
Atrial fibrillation and the cardiac surgeon: 902 Risk factors of supraventricular arrhythmias before and after surgical closure of atrial septal defect (ASD t.2) in adults
Europace 2005 7: 219; doi:10.1093/europace/7.s1.219-a
[PDF]
[Request Permissions]
Atrial fibrillation and the cardiac surgeon: 903 Intraoperative radiofrequency ablation to treat permanent atrial fibrillation in patients undergoing open heart surgery
Europace 2005 7: 219-220; doi:10.1093/europace/7.s1.219-b
[PDF]
[Request Permissions]
External electrical cardioversion: 928 Electrical cardioversion of atrial fibrillation with conscious sedation performed by cardiologist
Europace 2005 7: 220; doi:10.1093/europace/7.s1.220
[PDF]
[Request Permissions]
External electrical cardioversion: 929 Electrode type matters for external cardioversion of atrial fibrillation: the MOBIPAPA trial
Europace 2005 7: 220; doi:10.1093/europace/7.s1.220-a
[PDF]
[Request Permissions]
External electrical cardioversion: 930 Amiodarone or carvedilol pretreatment improves conversion rates in persistent atrial fibrillation patients - clinical and electrophysiological outcomes
Europace 2005 7: 220-221; doi:10.1093/europace/7.s1.220-b
[PDF]
[Request Permissions]
External electrical cardioversion: 931 PAF-ReVeSt - Prevention of atrial fibrillation in DDD-pacing by reduction of ventricular stimulation in patients with symptomatic sinus node disease?
Europace 2005 7: 221; doi:10.1093/europace/7.s1.221
[PDF]
[Request Permissions]
External electrical cardioversion: 932 Influence of maximum sensor rate programming on AF suppression performance
Europace 2005 7: 221; doi:10.1093/europace/7.s1.221-a
[PDF]
[Request Permissions]
External electrical cardioversion: 933 Effect of device parameters on the incidence of atrial arrhythmias in sick sinus syndrome patients utilizing pacemaker diagnostics
Europace 2005 7: 221; doi:10.1093/europace/7.s1.221-b
[PDF]
[Request Permissions]
Pacing and the grown up congenital heart disease: 916 Detrimental effect of apical ventricular pacing on ventricular dyssynchrony in patients with congenital heart block and narrow QRS escape rhythm
Europace 2005 7: 222; doi:10.1093/europace/7.s1.222
[PDF]
[Request Permissions]
Pacing and the grown up congenital heart disease: 917 Chronotropic incompetence in adult patients with congenital heart disease is related to exercise intolerance and indicates adverse outcome
Europace 2005 7: 222; doi:10.1093/europace/7.s1.222-a
[PDF]
[Request Permissions]
Pacing and the grown up congenital heart disease: 918 Automatic monitoring of ventricular pacing threshold in paediatric patients: endocardial vs epicardial leads
Europace 2005 7: 222; doi:10.1093/europace/7.s1.222-b
[PDF]
[Request Permissions]
Pacing and the grown up congenital heart disease: 919 Predictors of left ventricular remodelling and failure in right ventricular pacing in the young
Europace 2005 7: 223; doi:10.1093/europace/7.s1.223
[PDF]
[Request Permissions]
Pacing and the grown up congenital heart disease: 920 Outcome of cardiac pacing in congenital heart disease patients - thirty years and over 1300 patient-years of experience
Europace 2005 7: 223; doi:10.1093/europace/7.s1.223-a
[PDF]
[Request Permissions]
Pacing and the grown up congenital heart disease: 921 Capture management in children with epicardial pacing leads
Europace 2005 7: 223; doi:10.1093/europace/7.s1.223-b
[PDF]
[Request Permissions]
Cardiovascular and humoral interaction in syncope: 922 Cardiac contractility evaluation by tissue-Doppler echocardiography in neurally mediated syncope
Europace 2005 7: 224; doi:10.1093/europace/7.s1.224
[PDF]
[Request Permissions]
Cardiovascular and humoral interaction in syncope: 923 Interplay of cerebral autoregulation and neurovascular coupling evaluated by functional transcranial Doppler in different orthostatic positions
Europace 2005 7: 224; doi:10.1093/europace/7.s1.224-a
[PDF]
[Request Permissions]
Cardiovascular and humoral interaction in syncope: 924 The activation of renin-angiotensin-aldosterone system during cardiodepressive and mixed type of vasovagal reaction provoked by tilt test
Europace 2005 7: 224-225; doi:10.1093/europace/7.s1.224-b
[PDF]
[Request Permissions]
Cardiovascular and humoral interaction in syncope: 925 Heart rate variability and neurohumoral activation in patients with vasovagal syncope treated with tilt training program
Europace 2005 7: 225; doi:10.1093/europace/7.s1.225
[PDF]
[Request Permissions]
Cardiovascular and humoral interaction in syncope: 926 Activity of peripheral serotoninergic system in the pathogenesis of vasovagal syncope
Europace 2005 7: 225; doi:10.1093/europace/7.s1.225-a
[PDF]
[Request Permissions]
Cardiovascular and humoral interaction in syncope: 927 Baroreflex responses to head-up tilt in syncope patients: effects of daily repeated head-up tilt testing
Europace 2005 7: 225-226; doi:10.1093/europace/7.s1.225-b
[PDF]
[Request Permissions]
Application of mapping technique for catheter ablation: 940 Integration of MRI-based 3D cardiac modelling with classical fluoroscopy to enhance mapping and ablation
Europace 2005 7: 226; doi:10.1093/europace/7.s1.226
[PDF]
[Request Permissions]
Application of mapping technique for catheter ablation: 941 Integration of electroanatomic mapping and multidetector computed tomography as a guide for atrial fibrillation catheter ablation
Europace 2005 7: 226; doi:10.1093/europace/7.s1.226-a
[PDF]
[Request Permissions]
Application of mapping technique for catheter ablation: 942 A head to head comparison of multi-slice computed tomography versus intracardiac echocardiography to evaluate pulmonary vein anatomy prior to radiofrequency catheter ablation of atrial fibrillation
Europace 2005 7: 226-227; doi:10.1093/europace/7.s1.226-b
[PDF]
[Request Permissions]
Application of mapping technique for catheter ablation: 943 Usefulness of a non fluoroscopic navigation system during ectopic atrial tachycardia RF ablation
Europace 2005 7: 227; doi:10.1093/europace/7.s1.227
[PDF]
[Request Permissions]
Application of mapping technique for catheter ablation: 944 Magnetic navigation in ablation of right ventricular outflow tract tachycardias: a feasibility study
Europace 2005 7: 227; doi:10.1093/europace/7.s1.227-a
[PDF]
[Request Permissions]
Application of mapping technique for catheter ablation: 945 Electroanatomic features of right atrium in patients affected by myotonic dystrophy type 1
Europace 2005 7: 227-228; doi:10.1093/europace/7.s1.227-b
[PDF]
[Request Permissions]
Prediction of clinical response to CRT by mechanical dyssynchrony: 968 Frequency of left ventricular dyssynchrony in patients with advanced heart failure and a QRS complex =< 120 ms
Europace 2005 7: 228; doi:10.1093/europace/7.s1.228
[PDF]
[Request Permissions]
Prediction of clinical response to CRT by mechanical dyssynchrony: 969 Intraventricular dyssynchrony assessed by echocardiography using Color Kinesis is highly correlated with QRS duration
Europace 2005 7: 228; doi:10.1093/europace/7.s1.228-a
[PDF]
[Request Permissions]
Prediction of clinical response to CRT by mechanical dyssynchrony: 970 A new simple method for ventricular dyssynchrony evaluation by means of the left ventricular registry from coronary sinus
Europace 2005 7: 228-229; doi:10.1093/europace/7.s1.228-b
[PDF]
[Request Permissions]
Prediction of clinical response to CRT by mechanical dyssynchrony: 971 Biventricular and right-ventricular bifocal pacing improve severe heart failure by different mechanisms
Europace 2005 7: 229; doi:10.1093/europace/7.s1.229
[PDF]
[Request Permissions]
Prediction of clinical response to CRT by mechanical dyssynchrony: 972 Assessment of cardiac resynchronisation therapy by exercise Doppler-echocardiography in heart failure
Europace 2005 7: 229; doi:10.1093/europace/7.s1.229-a
[PDF]
[Request Permissions]
Prediction of clinical response to CRT by mechanical dyssynchrony: 973 Magnitude of ventricular dyssynchrony in adults with surgical repair of tetralogy of Fallot and prolonged right ventricular conduction
Europace 2005 7: 229-230; doi:10.1093/europace/7.s1.229-b
[PDF]
[Request Permissions]
Arrhythmias in uncommon heart diseases: 958 Investigation of undocumented arrhythmias in adults late after repair of tetralogy of Fallot: a risk stratification study
Europace 2005 7: 230; doi:10.1093/europace/7.s1.230
[PDF]
[Request Permissions]
Arrhythmias in uncommon heart diseases: 959 Left ventricular tei index is associated with QT indices in patients with systemic sarcoidosis
Europace 2005 7: 230; doi:10.1093/europace/7.s1.230-a
[PDF]
[Request Permissions]
Arrhythmias in uncommon heart diseases: 960 Adverse effect of pacemaker implantation on the natural history of patients with chronic heart failure due to Chagas' cardiomyopathy
Europace 2005 7: 231; doi:10.1093/europace/7.s1.231
[PDF]
[Request Permissions]
Arrhythmias in uncommon heart diseases: 961 Diagnostic value of plasma levels of brain natriuretic peptide in idiopathic ventricular arrhythmias
Europace 2005 7: 231; doi:10.1093/europace/7.s1.231-a
[PDF]
[Request Permissions]
Arrhythmias in uncommon heart diseases: 962 Diagnosis of arrhythmogenic right ventricular cardiomyopathy by 3 different sets of criteria
Europace 2005 7: 231; doi:10.1093/europace/7.s1.231-b
[PDF]
[Request Permissions]
Clinical follow up in ICD therapy: complications and how to avoid them: 963 The multicenter registry's experience with 1,322 ICD pulse generator and lead failures
Europace 2005 7: 232; doi:10.1093/europace/7.s1.232
[PDF]
[Request Permissions]
Clinical follow up in ICD therapy: complications and how to avoid them: 964 Warning systems concerning the performance of chronic lead systems in ICDs. Interim results from the Safe study
Europace 2005 7: 232; doi:10.1093/europace/7.s1.232-a
[PDF]
[Request Permissions]
Clinical follow up in ICD therapy: complications and how to avoid them: 965 Multi-center evaluation of rule-based telemetric monitoring of ICD patients
Europace 2005 7: 232-233; doi:10.1093/europace/7.s1.232-b
[PDF]
[Request Permissions]
Clinical follow up in ICD therapy: complications and how to avoid them: 966 Clinical impact of adverse events in dual-chamber ICD patients
Europace 2005 7: 233; doi:10.1093/europace/7.s1.233
[PDF]
[Request Permissions]
Clinical follow up in ICD therapy: complications and how to avoid them: 967 Can statins and IACE have antiarrhythmic action in patients with nonischaemic dilated cardiomyopathy and implanted cardioverter defibrillator? Results of multicenter study
Europace 2005 7: 233; doi:10.1093/europace/7.s1.233-a
[PDF]
[Request Permissions]
Poster Session 1
Moderated posters Basic science: 129 Changes of myocardial electrophysiology after stem cell transplantation
Europace 2005 7: 18; doi:10.1093/europace/7.s1.18
[PDF]
[Request Permissions]
Moderated posters Basic science: 130 Electrophysiology of the conductive heart system in one-year old infants
Europace 2005 7: 18; doi:10.1093/europace/7.s1.18-a
[PDF]
[Request Permissions]
Moderated posters Basic science: 131 Is there a predominant QRS complex polarity of the first ventricular fibrillation cycles in patients without structural heart disease?
Europace 2005 7: 18-19; doi:10.1093/europace/7.s1.18-b
[PDF]
[Request Permissions]
Moderated posters Basic science: 132 Enalapril in prevention recurrence of atrial fibrillation after electrical cardioversion
Europace 2005 7: 19; doi:10.1093/europace/7.s1.19
[PDF]
[Request Permissions]
Moderated posters Basic science: 133 Evidence of heritability of the common form of atrial fibrillation
Europace 2005 7: 19; doi:10.1093/europace/7.s1.19-a
[PDF]
[Request Permissions]
Moderated posters Basic science: 134 Comparison of the effects of nebivolol versus atenolol on heart rate variability in normal persons
Europace 2005 7: 19; doi:10.1093/europace/7.s1.19-b
[PDF]
[Request Permissions]
Moderated posters Basic science: 135 Different characteristics of the RR intervals detected by the ICD during induced sustained and non-sustained ventricular fibrillation
Europace 2005 7: 20; doi:10.1093/europace/7.s1.20
[PDF]
[Request Permissions]
Moderated posters Basic science: 136 Serum endothelin-1 and big endothelin levels are higher in patients with inducible ventricular tachyarrhythmias
Europace 2005 7: 20; doi:10.1093/europace/7.s1.20-a
[PDF]
[Request Permissions]
Moderated posters Basic science: 137 Mapping of ventricular fibrillation induced by acute ischemia in a porcine model
Europace 2005 7: 20; doi:10.1093/europace/7.s1.20-b
[PDF]
[Request Permissions]
Moderated posters Basic science: 138 Milrinone promotes ventricular tachyarrhythmias in the swine right ventricles
Europace 2005 7: 20-21; doi:10.1093/europace/7.s1.20-c
[PDF]
[Request Permissions]
Catheter ablation: results 1: 140 The recurrence rate of atrial fibrillation is lower in younger patients submitted previously to successful isthmus-dependent atrial flutter ablation
Europace 2005 7: 21; doi:10.1093/europace/7.s1.21
[PDF]
[Request Permissions]
Catheter ablation: results 1: 141 Usefulness of incremental atrial pacing for evaluating the effectiveness of perinodal slow pathway ablation
Europace 2005 7: 21; doi:10.1093/europace/7.s1.21-a
[PDF]
[Request Permissions]
Catheter ablation: results 1: 142 Novel approach for radiofrequency catheter ablation of AV nodal reentry tachycardia
Europace 2005 7: 21-22; doi:10.1093/europace/7.s1.21-b
[PDF]
[Request Permissions]
Catheter ablation: results 1: 143 Endocardial radiofrequency ablation of septal hypertrophy, a new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy
Europace 2005 7: 22; doi:10.1093/europace/7.s1.22
[PDF]
[Request Permissions]
Catheter ablation: results 1: 144 The influence of radiofrequency catheter ablation of right ventricle outflow tract on heart rate variability
Europace 2005 7: 22; doi:10.1093/europace/7.s1.22-a
[PDF]
[Request Permissions]
Catheter ablation: results 1: 145 Radiofrequency ablation in children and adolescents. Experience from a high-volume center
Europace 2005 7: 22-23; doi:10.1093/europace/7.s1.22-b
[PDF]
[Request Permissions]
Catheter ablation: results 1: 146 Mapping and ablation of non-isthmus dependent atrial re-entry tachycardias with non-contact mapping
Europace 2005 7: 23; doi:10.1093/europace/7.s1.23
[PDF]
[Request Permissions]
Catheter ablation: results 1: 147 Focal patterns of activation during atrial tachycardia in patients with surgically corrected congenital heart disease
Europace 2005 7: 23; doi:10.1093/europace/7.s1.23-a
[PDF]
[Request Permissions]
Catheter ablation: results 1: 148 Cryoablation of atrioventricular nodal reentry tachycardias (AVNRT)
Europace 2005 7: 23-24; doi:10.1093/europace/7.s1.23-b
[PDF]
[Request Permissions]
Catheter ablation: results 1: 149 Radiofrequency catheter ablation of multiple versus single accessory pathways: comparative results
Europace 2005 7: 24; doi:10.1093/europace/7.s1.24
[PDF]
[Request Permissions]
Catheter ablation: results 2: 151 Five o'clock small amplitude atrial electrograms mapping approach ablation in patients with typical persistent atrial flutter
Europace 2005 7: 24; doi:10.1093/europace/7.s1.24-a
[PDF]
[Request Permissions]
Catheter ablation: results 2: 152 Different incidence of atrial fibrillation after the treatment of typical atrial flutter
Europace 2005 7: 24-25; doi:10.1093/europace/7.s1.24-b
[PDF]
[Request Permissions]
Catheter ablation: results 2: 153 Quality of life in typical atrial flutter patients before and after radiofrequency catheter ablation using irrigational and conventional techniques
Europace 2005 7: 25; doi:10.1093/europace/7.s1.25
[PDF]
[Request Permissions]
Catheter ablation: results 2: 154 Previous therapy with antiarrhythmics, namely amiodarone, increases the recurrence rate of atrial flutter in successfully ablated isthmus-dependent atrial flutter patients
Europace 2005 7: 25; doi:10.1093/europace/7.s1.25-a
[PDF]
[Request Permissions]
Catheter ablation: results 2: 155 ECG patterns of isthmus dependent and non-dependent atrial macroreentry circuits
Europace 2005 7: 25; doi:10.1093/europace/7.s1.25-b
[PDF]
[Request Permissions]
Catheter ablation: results 2: 156 Alternatives to the first postpacing interval recorded from the pacing dipole following entrainment of ventricular tachycardia
Europace 2005 7: 25-26; doi:10.1093/europace/7.s1.25-c
[PDF]
[Request Permissions]
Catheter ablation: results 2: 157 Characteristics of endocardial electroanatomical substrate in patients with ischemic cardiomyopathy and non-ischemic cardiomyopathy
Europace 2005 7: 26; doi:10.1093/europace/7.s1.26
[PDF]
[Request Permissions]
Catheter ablation: results 2: 158 The posterior right atrial wall is a preferential site for successful ablation of atrial tachycardias in patients with tricuspid atresia
Europace 2005 7: 26; doi:10.1093/europace/7.s1.26-a
[PDF]
[Request Permissions]
Catheter ablation: results 2: 159 Bidirectional isthmus block in atrial flutter ablation unmasked by alternative parameter
Europace 2005 7: 26-27; doi:10.1093/europace/7.s1.26-b
[PDF]
[Request Permissions]
Catheter ablation: results 2: 160 CENTHER: Radiofrequency ablation of atrial flutter by irrigated tip - middle volume centers - two country experience
Europace 2005 7: 27; doi:10.1093/europace/7.s1.27
[PDF]
[Request Permissions]
Catheter ablation: results 3: 162 The impact of the bipolar and unipolar electrogram for guiding to localization and ablation in focal atrial tachycardia: Studied by the electroanatomical mapping
Europace 2005 7: 27; doi:10.1093/europace/7.s1.27-a
[PDF]
[Request Permissions]
Catheter ablation: results 3: 163 Radiofrequency catheter ablation for drug refractory electrical storm in implantable cardioverter defibrillator recipients
Europace 2005 7: 27-28; doi:10.1093/europace/7.s1.27-b
[PDF]
[Request Permissions]
Catheter ablation: results 3: 164 Radiofrequency catheter ablation did not cause cardiac dysfunction
Europace 2005 7: 28; doi:10.1093/europace/7.s1.28
[PDF]
[Request Permissions]
Catheter ablation: results 3: 165 Analysis of the electrical remodeling in patients with persistent atrial flutter. Importance of earliest reversion to sinus rhythm
Europace 2005 7: 28; doi:10.1093/europace/7.s1.28-a
[PDF]
[Request Permissions]
Catheter ablation: results 3: 166 Radiofrequency ablation without fluoroscopy in pregnant with permanent junctional reentrant tachycardia
Europace 2005 7: 28-29; doi:10.1093/europace/7.s1.28-b
[PDF]
[Request Permissions]
Catheter ablation: results 3: 167 Radiofrequency catheter ablation of hemodynamically unstable ventricular tachycardia
Europace 2005 7: 29; doi:10.1093/europace/7.s1.29
[PDF]
[Request Permissions]
Catheter ablation: results 3: 168 Epicardial ablation in an experimental model. Evaluation of the damage of the coronary arteries: irrigated tip vs standard catheter ablation
Europace 2005 7: 29; doi:10.1093/europace/7.s1.29-a
[PDF]
[Request Permissions]
Catheter ablation: results 3: 169 Comparison of presystolic purkinje and late diastolic potentials for selection of ablation site in idiopathic verapamil sensitive left ventricular tachycardia
Europace 2005 7: 29; doi:10.1093/europace/7.s1.29-b
[PDF]
[Request Permissions]
Catheter ablation: results 3: 170 The surface ECG is useful for distinguishing complete from incomplete block through the cavotricuspid isthmus
Europace 2005 7: 29-30; doi:10.1093/europace/7.s1.29-c
[PDF]
[Request Permissions]
Catheter ablation: results 3: 171 MRI-based three dimensional visualisation of the right atrium
Europace 2005 7: 30; doi:10.1093/europace/7.s1.30
[PDF]
[Request Permissions]
Interactions of pacing and neurovegetative system: 173 Impact of programmed lower rate, rate response, and paced AV delay on percentage ventricular and apical pacing in the bradycardia population
Europace 2005 7: 30; doi:10.1093/europace/7.s1.30-a
[PDF]
[Request Permissions]
Interactions of pacing and neurovegetative system: 174 Sleep Parameters in patients (Pt) using cardiac pacing (Integrity DR) (PM) with sleep rate function On/Off
Europace 2005 7: 31; doi:10.1093/europace/7.s1.31
[PDF]
[Request Permissions]
Interactions of pacing and neurovegetative system: 175 Optimization of intravascular vagal stimulation parameters
Europace 2005 7: 31; doi:10.1093/europace/7.s1.31-a
[PDF]
[Request Permissions]
Interactions of pacing and neurovegetative system: 176 Quality of life in patients with digital pacemakers
Europace 2005 7: 31; doi:10.1093/europace/7.s1.31-b
[PDF]
[Request Permissions]
Interactions of pacing and neurovegetative system: 177 Reflex bradycardia during rectal distension
Europace 2005 7: 31-32; doi:10.1093/europace/7.s1.31-c
[PDF]
[Request Permissions]
Interactions of pacing and neurovegetative system: 178 Comparison between short and long head-up tilt test potentiated with oral nitroglycerine: a randomised study
Europace 2005 7: 32; doi:10.1093/europace/7.s1.32
[PDF]
[Request Permissions]
Interactions of pacing and neurovegetative system: 179 Neurocardiogenic syncope in dilated cardiomyopathy
Europace 2005 7: 32; doi:10.1093/europace/7.s1.32-a
[PDF]
[Request Permissions]
Interactions of pacing and neurovegetative system: 180 Inhibition of unnecessary RV pacing with AV search hysteresis in ICDs (intrinsic RV): a randomized multicenter prospective trial
Europace 2005 7: 32-33; doi:10.1093/europace/7.s1.32-b
[PDF]
[Request Permissions]
Interactions of pacing and neurovegetative system: 181 A device based automatic post ventricular atrial refractory period (PVARP) algorithm
Europace 2005 7: 33; doi:10.1093/europace/7.s1.33
[PDF]
[Request Permissions]
Interactions of pacing and neurovegetative system: 182 Method for dynamic location of T wave by implanted cardiac pacemaker
Europace 2005 7: 33; doi:10.1093/europace/7.s1.33-a
[PDF]
[Request Permissions]
Atrial leads from acute to chronic: 184 A 10 years experience on 1073 patients fitted with 4 mm
2
atrial pacing leads
Europace 2005 7: 33-34; doi:10.1093/europace/7.s1.33-b
[PDF]
[Request Permissions]
Atrial leads from acute to chronic: 185 An atrial lead with variable bending stiffness to assure stable lead tip positioning
Europace 2005 7: 34; doi:10.1093/europace/7.s1.34
[PDF]
[Request Permissions]
Atrial leads from acute to chronic: 186 High success rate in introducing permanent stimulation/defibrillation leads via cephalic or retropectoral veins when using a guidewire and split introducer
Europace 2005 7: 34; doi:10.1093/europace/7.s1.34-a
[PDF]
[Request Permissions]
Atrial leads from acute to chronic: 187 Optimal side of implant for single lead VDD pacing: right-sided versus left-sided implantation
Europace 2005 7: 34-35; doi:10.1093/europace/7.s1.34-b
[PDF]
[Request Permissions]
Atrial leads from acute to chronic: 188 Compatibility of autocapture
TM
in patients with single atrial leads
Europace 2005 7: 35; doi:10.1093/europace/7.s1.35
[PDF]
[Request Permissions]
Atrial leads from acute to chronic: 189 Auto capture compatibility with previous implanted leads
Europace 2005 7: 35; doi:10.1093/europace/7.s1.35-a
[PDF]
[Request Permissions]
Atrial leads from acute to chronic: 190 Optimisation of the postventricular atrial blanking period significantly reduces inappropriate mode switch due to far-field r-wave sensing
Europace 2005 7: 35-36; doi:10.1093/europace/7.s1.35-b
[PDF]
[Request Permissions]
Atrial leads from acute to chronic: 191 Influence of post ventricular blanking period settings on auto mode switch frequency
Europace 2005 7: 36; doi:10.1093/europace/7.s1.36
[PDF]
[Request Permissions]
Atrial leads from acute to chronic: 192 Extraction of pacemaker and implantable cardioverter defibrillator leads: techniques and clinical results
Europace 2005 7: 36; doi:10.1093/europace/7.s1.36-a
[PDF]
[Request Permissions]
Atrial leads from acute to chronic: 193 Does LASER lead extraction affect venous patency? A prospective controlled evaluation
Europace 2005 7: 36; doi:10.1093/europace/7.s1.36-b
[PDF]
[Request Permissions]
Very intelligent pacemakers: 195 Therapy advisor: a programmer expert system to make pacemaker follow-up more efficient
Europace 2005 7: 37; doi:10.1093/europace/7.s1.37
[PDF]
[Request Permissions]
Very intelligent pacemakers: 196 The innovative fully digital pacemakers: may they improve our patients management?
Europace 2005 7: 37; doi:10.1093/europace/7.s1.37-a
[PDF]
[Request Permissions]
Very intelligent pacemakers: 197 An algorithm for automatic determination of pre-ventricular atrial blanking
Europace 2005 7: 37-38; doi:10.1093/europace/7.s1.37-b
[PDF]
[Request Permissions]
Very intelligent pacemakers: 198 Continuous monitoring of the native atrio-ventricular conduction in a dual chamber device
Europace 2005 7: 38; doi:10.1093/europace/7.s1.38
[PDF]
[Request Permissions]
Very intelligent pacemakers: 199 Permanent transfemoral pacemaker: a single-centre series performed with an easier and safer surgical technique
Europace 2005 7: 38; doi:10.1093/europace/7.s1.38-a
[PDF]
[Request Permissions]
Very intelligent pacemakers: 200 AAISAFER 2: a unique diagnosis tool
Europace 2005 7: 38; doi:10.1093/europace/7.s1.38-b
[PDF]
[Request Permissions]
Very intelligent pacemakers: 201 Comparison of interim results of two registries evaluating the use of vitatron's therapy advisor
Europace 2005 7: 39; doi:10.1093/europace/7.s1.39
[PDF]
[Request Permissions]
Very intelligent pacemakers: 202 AAISAFER 2: suppression of deleterious unnecessary ventricular pacing
Europace 2005 7: 39; doi:10.1093/europace/7.s1.39-a
[PDF]
[Request Permissions]
Very intelligent pacemakers: 203 Post depolarization integral based detection of breathing patterns using paced intracardiac electrograms
Europace 2005 7: 39; doi:10.1093/europace/7.s1.39-b
[PDF]
[Request Permissions]
Very intelligent pacemakers: 204 Evaluation of automatic capture detection using the atrial evoked response integral with and without upper body isometric exertion
Europace 2005 7: 40; doi:10.1093/europace/7.s1.40
[PDF]
[Request Permissions]
Tips and tricks for treatment of atrial fibrillation: 206 Predictors of recurrences in idiopathic atrial fibrillation
Europace 2005 7: 40; doi:10.1093/europace/7.s1.40-a
[PDF]
[Request Permissions]
Tips and tricks for treatment of atrial fibrillation: 207 Intraoperative ablation in patients with atrial fibrillation subjected to mitral valve replacement. Two years follow-up
Europace 2005 7: 40; doi:10.1093/europace/7.s1.40-b
[PDF]
[Request Permissions]
Tips and tricks for treatment of atrial fibrillation: 208 Long term results of radiofrequency ablation of common atrial flutter: role of the validation criteria of inferior vena cava-tricuspid isthmus block
Europace 2005 7: 41; doi:10.1093/europace/7.s1.41
[PDF]
[Request Permissions]
Tips and tricks for treatment of atrial fibrillation: 209 Signal-averaged P wave duration in patients with atrial fibrillation treated with radiofrequency catheter ablation
Europace 2005 7: 41; doi:10.1093/europace/7.s1.41-a
[PDF]
[Request Permissions]
Tips and tricks for treatment of atrial fibrillation: 210 The predictive value of 6 weeks monitoring for the further development of atrial fibrillation: the role of pacemaker diagnostics
Europace 2005 7: 41; doi:10.1093/europace/7.s1.41-b
[PDF]
[Request Permissions]
Tips and tricks for treatment of atrial fibrillation: 211 Long-term evaluation of an individualized approach to AF preventive pacing
Europace 2005 7: 41-42; doi:10.1093/europace/7.s1.41-c
[PDF]
[Request Permissions]
Tips and tricks for treatment of atrial fibrillation: 212 Atrial pacing site influences differently right and left atrial pressures
Europace 2005 7: 42; doi:10.1093/europace/7.s1.42
[PDF]
[Request Permissions]
Tips and tricks for treatment of atrial fibrillation: 213 Effect of nocturnal atrial overdrive pacing on AV nodal conduction in SSS patients with sleep apnea
Europace 2005 7: 42; doi:10.1093/europace/7.s1.42-a
[PDF]
[Request Permissions]
Tips and tricks for treatment of atrial fibrillation: 214 A randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from bradycardia and atrial fibrillation and implanted with a DDDRP device
Europace 2005 7: 42-43; doi:10.1093/europace/7.s1.42-b
[PDF]
[Request Permissions]
Tips and tricks for treatment of atrial fibrillation: 215 Improved efficacy of atrial overdrive pacing in patients with atrial figrillation using hybrid-therapy (Amiodorane or right atrial linear ablation). 8 months results of the Medab-Study
Europace 2005 7: 43; doi:10.1093/europace/7.s1.43
[PDF]